The present studies were designed to assess the roles of progesterone (P4) and Progesterone Receptor Membrane Component 1 (PGRMC1) in regulating mitosis of spontaneously immortalized granulosa cells (SIGCs) and ovarian cancer cells, SKOV-3 cells. Because PGRMC1 has been detected among the proteins of the human mitotic spindle, we theorized that P4 and PGRMC1 could affect mitosis through a microtubule-dependent process. The present study confirms that SIGC growth is slowed by either P4 treatment or transfection of a PGRMC1 antibody. In both cases, slower cell proliferation was accompanied by an increased percentage of mitotic cells, which is consistent with a P4-induced prolongation of the M phase of the cell cycle. In addition, P4 increased the stability of the spindle microtubules, as assessed by the rate of beta-tubulin disassembly in response to cooling. Also, P4 increased spindle microtubule stability of SKOV-3 cells. This effect was mimicked by the depletion of PGRMC1 in these cells. Importantly, P4 did not increase the stability of the microtubules over that observed in PGRMC1-depleted SKOV-3 cells. Immunofluorescent analysis revealed that PGRMC1 is distributed to the spindle apparatus as well as to the centrosomes at metaphase. Further in situ proximity ligation assay revealed that PGRMC1 interacted with beta-tubulin. Taken together, these results suggest that P4 inhibits mitosis of ovarian cells by increasing the stability of the mitotic spindle. Moreover, P4's actions appear to be dependent on PGRMC1's function within the mitotic spindle.
INTRODUCTION
Progesterone (P4) regulates female reproduction by influencing the function of several organs, including the hypothalamus [1, 2] , the pituitary [1, 2] , the mammary gland [3] , and the uterus [3, 4] . Progesterone also has an intraovarian site of action where it influences different aspects of granulosa cell function, including those related to slowing the rate of granulosa cell mitosis and follicular growth (reviewed in Peluso [5] and Gellersen et al. [6] ).
The effect of P4 on cell proliferation is cell type and dose dependent. Regarding the ovary, P4's inhibitory effect on granulosa cell proliferation has been observed both in vivo and in vitro [7] [8] [9] [10] [11] [12] . In vitro, both nanomolar and micromolar concentrations of P4 inhibit proliferation of primary rat granulosa cells and spontaneously immortalized granulosa cells (SIGCs) [10] . In contrast, nanomolar concentrations of P4 stimulate proliferation of the ovarian surface epithelial cells as well as on ovarian cancer cell lines that are derived from these cells, whereas micromolar doses of P4 exert a marked antiproliferative effect on these cells [13, 14] . Thus, although P4 has dose-dependent effects depending on ovarian cell type, it is clear that micromolar P4 inhibits proliferation of cells derived from either primary granulosa cells or ovarian cancers. Importantly, the growth inhibitory effects of P4 that are observed at micromolar concentrations are physiologically relevant because follicular fluid concentrations of P4 in the rat ovary vary from a low of about 4 lM on diestrus I to a high of '57 lM on proestrus [15] .
Despite its biological relevance, little is known about the mechanisms that are involved in regulating P4's antiproliferative activity in ovarian cells. A possible mediator of P4's action is Progesterone Receptor Membrane Component 1 (PGRMC1). Several lines of evidence support this hypothesis. Specifically, PGRMC1-depleted ovarian cancer cells (SKOV-3) [16] , A549 non-small cell lung cancer cells [17] , and MDA-MB-468 breast cancer cells [17] all grow slower in vitro than their parental cells. Finally, tumors derived from ovarian and breast cancer cells in which PGRMC1 expression was depleted by stable expression of short hairpin RNA grow slower than tumors derived from their respective parental cell lines [16, 17] .
Progesterone's ability to inhibit the complex events involved in mitosis likely involves the regulation of numerous signal transduction pathways. Clearly, some of these P4-regulated pathways could involve PGRMC1. One possible site of PGRMC1's action is the mitotic spindle, because a phosphoproteome analysis detected PGRMC1 among the proteins of HeLa cell spindle extract [18] . Based on these observations, the present studies were designed to test the hypothesis that P4 and PGRMC1 slow the rate of ovarian cell mitosis, in part through a direct effect on the mitotic spindle.
MATERIALS AND METHODS

Cell Lines and Culture
All of the chemicals used in this study were purchased from Sigma Chemical Co. (St. Louis, MO), except for those specifically mentioned. The SIGCs (provided by Dr. Robert Burghardt, Texas A&M University, College Station, TX) were derived from rat granulosa cells isolated from preovulatory follicles as described by Stein et al. [19] . The human ovarian epithelial cancer cell line, SKOV-3, was obtained from the American Type Culture Collection (Manassas, VA). The PGRMC1-depleted SKOV-3 cell line (dsRed SKOV-3 PGRMC1 depleted) was obtained by stable expression of interfering short hairpin RNA in dsRed-expressing SKOV-3 cell line (dsRed SKOV-3), as described elsewhere [16] .
Except where noted, cells were cultured in growth medium, which was Dulbecco modified Eagle medium/F12 supplemented with 5% of fetal bovine serum (FBS; HyClone, Logan, UT), 100 U/ml penicillin G, and 100 lg/ml streptomycin, as previously described [10, 16] . When the effect of P4 on cell proliferation and spindle microtubule stability was evaluated (see below), the culture medium was supplemented with 5% of charcoal/dextran-treated FBS with reduced steroid levels (Hyclone). The dsRed-expressing SKOV-3 cells were maintained in growth medium supplemented with 100 lg/ml geneticin (GIBCO-Invitrogen, Grand Island, NY).
Unless otherwise indicated, a total of 4 3 10 5 cells were plated in 2 ml of medium in either 35-mm culture dishes (Greiner Bio-One GmbH, Frickenhausen, Germany), glass-bottom culture dishes (Mat Tek Corp., Ashland, MA), or on cover glasses in 35-mm culture dishes. Regardless of culture vessel, the cells were incubated for 24 h at 378C with 5% CO 2 in a humidified atmosphere and then fixed for immunofluorescent staining or treated according to the experimental design. For Western blot analysis, a total of 4 3 10 6 cells were plated in 100-mm cell culture dishes and cultured for 24 h as described above prior to cell harvesting.
Immunodetection of PGRMC1
Western blot analysis. PGRMC1 was detected in whole-cell lysates obtained from SIGCs, dsRed SKOV-3, and dsRed SKOV-3 PGRMC1-depleted cells by Western blot analysis as previously described [16, 20] . Cells were lysed in RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, and 1% Nonidet P-40, 0.25% Na deoxycolate), supplemented with protease and phosphatase inhibitors as previously described [20] . All procedures were conducted on ice. Total amount of protein was determined using the BCA assay kit from Pierce Biotechnology (Rockford, IL), and 10 lg of total protein was used for Western blot analysis. PGRMC1 immunodetection was conducted using a rabbit polyclonal antibody raised against amino acids 1-46 mapping at the N-terminus of PGRMC1 of human origin (catalogue no. sc-98680; Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:200. PGRMC1 was revealed using an anti-rabbit horseradish peroxidase-labeled antibody (1:2000) and ECL detection (GE Healthcare, Chalfont St. Giles, U.K.). Negative controls were conducted by omitting the primary antibody. When PGRMC1 expression analysis was conducted on dsRed SKOV-3 and dsRed SKOV-3 PGRMC1-depleted cells, the nitrocellulose membrane was stripped in stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl [pH 6.7]) at 508C for 30 min and reprobed with a GAPDH polyclonal antibody (catalogue no. AM4300; Ambion Inc., Austin, TX) at dilution 1:4000. This was done to confirm that equal amounts of total protein were loaded during the procedure. This served also as a control for the specificity of the anti-PGRMC1 antibody used in this study.
Immunofluorescence. Double immunofluorescent staining was conducted to colocalize PGRMC1 with either b-tubulin or c-tubulin in 4% paraformaldehyde-fixed SKOV-3 cells. After fixation, cells were permeabilized with 0.1% Triton X-100 in PBS for 7 min and blocked with 3% bovine serum albumin in PBS for 1 h.
For the colocalization study of PGRMC1 and c-tubulin, the samples were incubated overnight at 48C with a solution of rabbit polyclonal anti-PGRMC1 antibody (1:500; catalogue no. sc-98680; Santa Cruz Biotechnology) and mouse monoclonal anti-c-tubulin antibody (1:1000; clone GTU-88; catalogue no. T5326; Sigma-Aldrich, St. Louis, MO). Primary antibodies were detected with Alexa Fluor 546-labeled anti-rabbit and Alexa Fluor 488-labeled antimouse antibodies (Molecular Probes, Eugene, OR), respectively. For the colocalization study of PGRMC1 and b-tubulin, primary and secondary antibodies were incubated sequentially. b-Tubulin was immunodetected by using a mouse monoclonal anti-b-tubulin antibody (1:400; clone TUB 2.1; catalogue no. T4026; Sigma-Aldrich). All primary and secondary antibodies were diluted in 4% FBS in PBS. As negative controls, normal rabbit and/or mouse immunoglobulin G (IgG; Santa Cruz Biotechnology) were used in place of the primary antibodies. After DNA counterstaining with Hoechst 33342, samples were mounted on slides with ProLong antifade reagent (InvitrogenMolecular Probes) and analyzed on a Zeiss Axio Observer inverted microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY) equipped with both a Lumen 200 Fluorescence Illumination Systems (Prior Scientific Inc., Rockland, MA) and a QImaging Retiga EXi CCD digital camera (QImaging, Surrey, BC). Immunofluorescence was performed to assess the possible role of P4 in perturbing PGRMC1 localization on the spindle apparatus. To this purpose, cells were incubated for 7 min, 24 h, 48 h, and 72 h with either vehicle or 4 lM P4 and then processed as described above.
PGRMC1 immunostaining was also performed on both dsRed SKOV-3 and dsRed SKOV-3 PGRMC1-depleted cells as described above, with the exception that the secondary antibody was Alexa Fluor 488-labeled goat anti-rabbit. Images were captured under identical exposure times and gain settings. The total fluorescence intensity (FI) of the PGRMC1 staining in the spindle of metaphase cells was determined with the iVision-Mac Image Acquisition and Analysis Software (BioVision Technologies, Exton, PA) using the Hoechst-stained metaphase plate to identify the presumptive area of the spindle. In addition, the background FI was estimated by determining the average of the FI of the presumptive spindle areas in the IgG control group. Specific PGRMC1 FI was calculated by subtracting the background FI from the total PGRMC1 FI.
Antibody-Mediated Interference with PGRMC1 Function
In order to perturb PGRMC1 function in SIGCs, the anti-PGRMC1 antibody was delivered into the cells using the Chariot transfection reagent (Active Motif, Carlsbad, CA) as previously described [21] . This technology has successfully been applied to delivering antibodies into cells while preserving their ability to recognize their target antigens [22] . To demonstrate the feasibility and effectiveness of this approach, a total of 2 3 10 5 SIGCs were plated in glass-bottom culture dishes and cultured for 48 h prior to being transfected. Briefly, 12 lg of Chariot transfection agent was diluted in water and incubated for 30 min at room temperature with either PBS or 5 lg of Alexa Fluor 488-labeled IgG in PBS. Transfection was carried out by incubating SIGCs with the above mixture for 1 h at 378C in serum-free Optimem (GIBCOInvitrogen), according to the manufacturer's instructions. Thereafter, complete growth medium was added without removing the transfection mixture, and the cells were incubated for additional 2 h before being washed and observed under fluorescent microscopy to assess transfection efficiency. Alexa 488-IgG was not incorporated into the SIGCs unless the transfection agent was present. Moreover, in the presence of the transfection agent, transfection efficiency was estimated to be nearly 100%, confirming our previous study [21] (Supplemental Fig. S1 , available online at www.biolreprod.org).
Having established that this protocol was highly effective in transfecting the SIGCs, it was used to deliver either the anti-PGRMC1 antibody or normal rabbit IgG into SIGCs. After transfection, the medium was replaced with growth medium, and cells were treated according to the experimental design to assess the effect on cell proliferation.
Cell Proliferation and Mitotic Index Assays
In order to assess the effect of P4 treatment on SIGC proliferation, cells were plated in growth medium supplemented with 5% charcoal/dextran-treated FBS, into 35-mm culture dishes to which a horizontal and two vertical axes were scribed on the bottom outer surface. After 3 h, cells were washed to remove any unattached cells and the cells cultured in growth medium with or without (CTRL) 4 lM P4. In the CTRL group, an equivalent amount of ethanol that was used to dissolve P4 was added. Bright-field images of the eight areas that were formed at the intersection of the horizontal and each vertical axis were taken. After 24 and 48 h of culture, images of the same eight areas were taken. The total number of cells present in each area was counted either manually or using the iVision-Mac Image Acquisition and Analysis Software. Cell proliferation was expressed as the fold increase in cell number over the Time 3 h value. In addition, the number of mitotic cells was recorded and expressed as a percentage of the total number of cells (mitotic index).
In order to assess the effect of perturbing PGRMC1 on SIGC proliferation, cells were transfected with either IgG or the anti-PGRMC1 antibody as described above. After 3 h of transfection, the medium was replaced with growth medium and cultured for an additional 21 h. In this experiment, pictures were taken from the same field of view at 3 and 21 h after transfection. The fold increase in cell number was calculated as described above. In order to calculate the mitotic index, cells were fixed in stabilization buffer (0.1 M PIPES [pH 6 .75]; 1 mM ethylene glycol tetraacetic acid; 1 mM MgSO 4 ; 4% polyethylene glycol 6000; 1% Triton X; and 2% formaldehyde) for 10 min at 378C, postfixed in methanol for 5 min at À208C, and immunostained for b-tubulin as described above. Cells were analyzed under fluorescent microscopy. For each treatment, 10-15 fields were randomly selected, and the number of cells in metaphase, anaphase, telophase, and cytokinesis was recorded. The total number of cells was counted in each field, and the mitotic index was calculated as described above. An average of 400-1000 cells were counted for each treatment in each replicate.
In Vivo Disassembly/Reassembly of Spindle Microtubules
After various treatments, the cells were fixed either 1) immediately or 2) after incubation on ice for up to 60 min or 3) after incubation on ice for 60 min and rewarming by replacing the medium with warm medium and incubating for an additional 7 min at 378C. As outlined in each experiment, cells were fixed in 100% methanol for 7 min at À208C and then immunostained for b-tubulin to reveal the spindle as described above, with the exception that the incubation with the b-tubulin antibody was performed overnight at 48C. Samples were analyzed under fluorescent microscopy, and images of randomly selected 
In Situ Proximity Ligation Assay
The interaction between PGRMC1 and either b-tubulin or c-tubulin was assessed by using the in situ Proximity Ligation Assay (PLA; Duolink II; OLINK Bioscience, Uppsala, Sweden) in SKOV-3 cells. This technology allows for detection of protein-protein interaction in fixed cells using a pair of oligonucleotide-labeled secondary antibodies (PLA probes), which generate a signal only when the two probes have bound in close proximity (http://www. olink.com/). The signal from each detected pair of PLA probes is visualized as an individual fluorescent spot. Duolink in situ PLA was performed as recommended by the manufacturer, with the exception that primary and secondary PLA probes were incubated sequentially. Samples were prepared as described above for immunofluorescence. Primary antibodies used were the mouse anti-b-tubulin, rabbit anti-a-tubulin (catalogue no. 2125; Cell Signaling Technology, Danvers, MA) as a positive control, and the indicated primary antibody pairs. The PLA probes used were the anti-rabbit PLUS and the antimouse MINUS. Negative control was performed omitting one of the two primary antibodies. In situ PLA was also performed to assess the possible role of P4 in perturbing PGRMC1-b-tubulin interaction. To this purpose, cells were incubated for 7 min with ether vehicle or 4 lM P4 and then processed as described above.
Statistical Analysis
All experiments were repeated two to four times, and data are presented as the mean 6 SEM. Statistical significance was determined by Student unpaired t-test when means of two different groups were being compared. Means from three or more groups were compared using an ANOVA followed by a Tukey multiple-comparison test. Regardless of the statistical test, P values of ,0.05 were considered significant. Figure 1A , P4 treatment suppressed the seruminduced increase in SIGC number after 48 h of culture in growth medium (P , 0.05) compared with the control group. This was accompanied by a significant increase in the percentage of mitotic cells (P , 0.05; Fig. 1B) . The P4-induced increase in the percentage of mitotic figures indicates that P4 prolongs the duration of the mitotic phase of the cell cycle.
RESULTS
As shown in
Because P4 could be mediating its action through PGRMC1, we assessed the extent to which blocking the function of PGRMC1 with an antibody could affect the fold increase in cell number and the mitotic index. Spontaneously immortalized granulosa cells were transfected with either IgG or PGRMC1 antibody. As shown in Figure 2A , the PGRMC1 antibody used specifically recognized PGRMC1 in SIGCs, as revealed by Western blot analysis. When this antibody was transfected into SIGCs, the fold increase in cell number was reduced compared with the IgG control group (P , 0.05; Fig.  2B ). In addition, the mitotic index (percentage of mitotic figures) was increased by PGRMC1 antibody treatment (P , 0.05; Fig. 2C ).
Progesterone could influence the duration of mitosis by altering the rate of spindle microtubule disassembly and reassembly. To test this, the rate of disassembly and 
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reassembly was estimated by sequentially exposing SIGCs to cold treatment to induce disassembly, and rewarming to stimulate reassembly [23, 24] . As shown in Figure 3 , A and B, the FI of the mitotic spindle decreased to approximately 30% of its initial value (P , 0.05) after 15 min of cooling and remained at this level for up to 60 min. After 7 min at 378C, the metaphase spindle reassembled to 75% of the initial FI. The presence of P4 during the cooling procedure slowed down the rate of microtubule disassembly after 3 and 7 min of incubation on ice (P , 0.05; Fig. 3C ). Progesterone was not effective in inhibiting microtubule disassembly after 60 min of cooling and did not affect the process of reassembly after rewarming (data not shown). These data indicate that P4 increases the stability of the spindle microtubules in response to cooling.
Because the presence of the antibody makes it technically difficult to more clearly define the relationship between P4, PGRMC1, and mitotic spindle stability, subsequent studies were designed to assess PGRMC1's role in regulating spindle stability by comparing the effect of P4 on parental dsRed SKOV-3 and PGRMC1-depleted dsRed SKOV-3 cells. That PGRMC1 was effectively reduced in the PGRMC1-depleted dsRed SKOV-3 cells was confirmed by Western blot analysis (Fig. 4A) . Interestingly, depleting PGRMC1 in dsRed SKOV-3 cells significantly slowed the rate of the spindle microtubule disassembly after 7 min of incubation on ice (P , 0.05; Fig.  4B ). As observed for SIGCs, treating dsRed SKOV-3 cells with P4 slowed the rate of microtubule disassembly in response to cooling compared with the control group (P , 0.05; Fig.  4C ). PGRMC1 depletion also slowed that rate of disassembly, mimicking the effect of P4 seen in the parental dsRed SKOV-3. Further, the rate of spindle microtubule disassembly in the PGRMC1-depleted cells dsRed SKOV-3 was not influenced by the presence of P4 (Fig. 4C) .
Because PGRMC1 influences spindle microtubule stability, its presence on the mitotic spindle of SKOV-3 cells was determined by colocalizing PGRMC1 with b-tubulin (Fig. 5A) . At metaphase, PGRMC1 localized to the spindle apparatus, as indicated by its colocalization with b-tubulin (Fig. 6A, top  row) . PGRMC1 was also present at the mitotic spindle poles, suggesting that it localizes to the centrosome. The centrosome localization was confirmed, because PGRMC1 colocalized with c-tubulin, a specific marker of centrosomes [25] . PGRMC1 also localized to the midzone and the midbody (Fig. 5B) at anaphase/telophase and cytokinesis, respectively ( Fig. 5B) . When the effect of P4 treatment on PGRMC1 localization to the spindle apparatus was assessed, no differences were observed between treated and control groups (not shown).
In addition, immunofluorescence analysis confirmed and expanded Western blot analysis (Fig. 4A) by showing a marked reduction of PGRMC1 immunostaining in metaphase PGRMC1-depleted dsRed SKOV-3 (Fig. 6 ). In particular, the FI of PGRMC1 in the spindle area was reduced by 63% (P , 0.05) compared with the parental dsRed SKOV-3 cells (mean 6 SEM FI values were calculated on a total of 22 and 28 cells, respectively, and were 39.25 6 20.04 for PGRMC1-depleted dsRed SKOV-3 cells, and 106.56 6 27.07 for parental dsRed SKOV-3 cells).
Because colocalization data are not indicative of a physical association between PGRMC1 and b-tubulin or c-tubulin, an in situ PLA was used to determine whether PGRMC1 directly interacts with either b-tubulin or c-tubulin in mitotic cells. To confirm the efficiency of this technique, the interaction between a-tubulin and b-tubulin, which are known to form a heterodimer during microtubule polymerization [26] , was assessed. As expected, immunofluorescent studies confirmed the colocalization of a-tubulin and b-tubulin in the mitotic spindle (Fig. 7A, top row) , and the PLA detected a direct interaction (Fig. 7A, middle row) . Negative controls were carried out by omitting one of the primary tubulin antibodies and did not reveal any signal (Fig. 7A, bottom row) . As shown in Figure 7B , upper row, the PLA also demonstrated a clear interaction between PGRMC1 and b-tubulin. On the contrary, a direct interaction between PGRMC1 and c-tubulin was not detected by PLA (Fig. 7B, lower row) , even through these two proteins colocalized (Fig. 5A ). This observation thereby illustrates the specificity of the PLA. Finally, P4 treatment did not affect the amount of PGRMC1-b-tubulin interaction, as judged by the intensity of the PLA signal (data not shown).
DISCUSSION
Previous work has shown that P4 inhibits mitosis of rat granulosa cells, human granulosa/luteal cells [7] , and SIGCs [10] . Progesterone has also been shown to have a dosedependent effect on proliferation of ovarian cancer cells, stimulating proliferation at nanomolar concentrations but inhibiting growth micromolar concentrations [13, 14] . The present studies expand these observations by demonstrating that a component of P4's antimitotic action involves its ability to increase the percentage of mitotic figures. This suggests that P4 regulates the rate at which cells progress through the M phase of the cell cycle.
Mitotic progression is a dynamic process that primarily depends on the formation and function of the mitotic spindle. The key structural components of the mitotic spindle are the microtubules, which are composed of polymers of a-tubulin and b-tubulin (reviewed in Desai and Mitchison [26] ). The microtubules dynamically assemble and disassemble to ''search out'' and bind to the condensed chromosomes. Once in contact with chromosomes, the microtubules promote chromosomal segregation into two daughter cells (reviewed in Gadde and Heald [27] ).
In previous studies, P4's effect on microtubule assembly has been tested by monitoring the in vitro assembly (polymerization) of purified tubulin [28] [29] [30] . These studies showed that although P4 binds the microtubule-associated protein 2 (MAP2), micromolar doses of P4 do not stimulate microtubule assembly. In contrast, P4 antagonizes pregnenolone's ability to bind MAP2 and to stimulate MAP2-dependent microtubule assembly [28] [29] [30] . Although P4 failed to affect the assembly of purified tubulin in vitro, this does not necessarily mean that P4 does not influence microtubule function. This is because this in vitro system has two major limitations. First, it cannot assess the stability of the microtubules, and second, it does not reflect the complexities involved in microtubule stability in a living cell [27, 31] .
The present study used an intact cell system in which the stability of the mitotic spindle can be assessed in a quantitative manner. Using this approach, our studies are the first to demonstrate that P4 increases spindle microtubule stability as judged by its ability to inhibit the disassembly of the mitotic spindle in response to cooling. The P4-induced stability of the microtubules could impede the ability of the microtubules to establish an appropriate contact with the chromosomes and/or interfere with microtubule-dependent segregation of the metaphase chromosomes. Either of these possibilities could account in part for P4's ability to increase the percentage of mitotic figures. This concept is consistent with the experimental evidence that demonstrates that P4 1) facilitates chromosome instability, which leads to aberrant chromosomal segregation (i.e., aneuploidy) in p53 null mammary epithelial cells [32, 33] , and 2) promotes abnormal mitoses in rat liver [34] .
How P4 promotes stability of the spindle microtubules is not known. Insight into the mechanism of P4's action is provided by the observation that PGRMC1 localizes to the mitotic spindle apparatus, where it not only colocalizes with but also physically interacts with b-tubulin, as revealed by PLA. A comparison of the effects of P4 and PGRMC1 depletion reveals that both of these treatments increase microtubule stability and suppress cell proliferation. The fact that depleting PGRMC1 from the mitotic spindle has the same effect as P4 treatment suggests that P4 acts to prevent PGRMC1 from exerting its function on the mitotic spindle, thus affecting the spindle stability, and ultimately the mitotic progression.
Surprisingly, P4 treatment altered neither PGRMC1's localization to the spindle apparatus, nor its direct interaction with b-tubulin. However, P4 would not necessarily have to remove PGRMC1 from the microtubules in order to affect its stability. For example, P4 could alter PGRMC1's action by changing its phosphorylation status, because it is known that PGRMC1 on the human mitotic spindle is phosphorylated at serine 180 [18] . It is possible, then, that P4 binding to PGRMC1 could promote its phosphorylation by one of the numerous kinases that are present at specific sites along the mitotic spindle [35, 36] . This, in turn, could alter spindle microtubule stability, and ultimately control the rate of mitotic progression. Support for this hypothesis comes from the observation that PGRMC1 colocalizes with active-form Aurora B kinase during oocyte meiosis [37] . Therefore, in future studies, it will be important to determine whether PGRMC1 localization and/or interaction with b-tubulin are dependent on its phosphorylation status, and whether this is regulated by P4.
Finally, it is important to appreciate that P4-PGRMC1 interaction does not always result in the suppression of mitosis. In neural progenitor cells, P4 stimulates ERK activity, and ultimately cell proliferation [38] . Moreover, P4's ability to induce ERK activity and promote entry into the cell cycle is dependent on PGRMC1 [38] . Conversely, in SIGCs, P4 suppresses ERK activity [39] and inhibits mitosis (the present study and Peluso et al. [10] ). The reason for the different responses is unclear but may be related to the expression of various progestin receptors within a given cell type. Interestingly, progestin and adipoQ receptors (PAQRs) increase the activity of ERK in response to P4 treatment (Karteris et al. [40] and Zhu et al. [41] ; reviewed in Peluso [42] ). It is possible that the neural progenitor cells express PAQRs, whereas SIGCs may not express these receptors. Thus, the putative tissuespecific expression of PGRMC1 and PAQRs, as well as the nuclear progesterone receptors A and B, could account for differing responses to P4 that are observed in neural progenitor cells compared with SIGC and SKOV-3 cells.
In summary, the results presented in this study suggest that in SIGCs and SKOV-3 cells, micromolar doses of P4 slow cell proliferation and delay mitotic progression, possibly through the regulation of a microtubule-dependent process. Progesterone's action appears to be mediated in part by PGRMC1, suggesting a crucial role for PGRMC1 during ovarian cell mitosis. The precise relationship between P4 and PGRMC1 is 
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not known, but P4-PGRMC1 interactions could regulate the stability of the microtubules, and thereby govern the rate of mitosis.
